Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy

被引：3
|
作者：
Montefiori, David C. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 08期
关键词：
neutralizing antibodies; HIV; vaccines; correlates; sieve; STANDARDIZED ASSESSMENTS; MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; ENV CLONES; PROTECTION; INFECTION; RESPONSES; ASSAY; TRANSMISSION; IMMUNIZATION;
D O I：
10.4161/hv.28950
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2507 / 2511
页数：5
相关论文
共 50 条
  • [21] Neutralization of HIV-1 by antibody
    Sattentau, QJ
    CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) : 540 - 545
  • [22] Antibody neutralization and its determinants in HIV-1 infected patients from Portugal: implications for vaccine design and efficacy
    Goncalves, Patricia
    Marcelino, Rute
    Calado, Rita
    Martin, Francisco
    Goncalves, Paloma
    Janeiro, Nuno
    Neno, Miguel
    Afonso, Claudia
    Badura, Robert
    Gramacho, Filipa
    Brogueira, Pedro
    Mansinho, Kamal
    Valadas, Emilia
    Caldeira, Luis
    Taveira, Nuno
    Marcelino, Jose M.
    ANNALS OF MEDICINE, 2019, 51 : S89 - S90
  • [23] Immune correlates of vaccine protection against HIV-1 acquisition
    Corey, Lawrence
    Gilbert, Peter B.
    Tomaras, Georgia D.
    Haynes, Barton F.
    Pantaleo, Giuseppe
    Fauci, Anthony S.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (310)
  • [24] Lessons from HIV-1 vaccine efficacy trials
    Excler, Jean-Louis
    Michael, Nelson L.
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (06) : 607 - 613
  • [25] Direct Antibody Access to the HIV-1 MPER Positively Correlates with Neutralization Sensitivity
    Chakrabarti, B. K.
    Walker, L. M.
    Guenaga, J. F.
    Ghobbeh, A.
    Poignard, P.
    Burton, D. R.
    Wyatt, R. T.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A24 - A24
  • [26] Roles of HIV-1 Env variable regions in viral neutralization and vaccine development
    Pinter, Abraham
    CURRENT HIV RESEARCH, 2007, 5 (06) : 542 - 553
  • [27] Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials
    Baeten, JM
    Richardson, BA
    Martin, HL
    Nyange, PM
    Lavreys, L
    Ngugi, EN
    Mandaliya, K
    Ndinya-Achola, JO
    Bwayo, JJ
    Kreiss, JK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (05) : 458 - 464
  • [28] Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
    P Munseri
    A Kroidl
    C Nilsson
    C Moshiro
    S Aboud
    A Joachim
    C Geldmacher
    E Aris
    D Buma
    E Lyamuya
    F Gotch
    K Godoy-Ramirez
    K Pallangyo
    L Maboko
    M Marovich
    M Robb
    M Hoelscher
    M Janabi
    P Mann
    S Joseph
    S Mfinanga
    W Stoehr
    F Mhalu
    B Wahren
    G Biberfeld
    S McCormack
    E Sandstrom
    M Bakari
    Retrovirology, 9
  • [29] Multiple immune effector mechanisms as correlates of HIV-1 vaccine protection
    Heeney, JL
    Mooij, P
    Bogers, W
    Davis, D
    Morein, B
    Morghen, CD
    Lehner, T
    Voss, G
    Bruck, C
    Koopman, G
    Rosenwirth, B
    11E COLLOQUE DES CENT GARDES: RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1998, : 281 - 285
  • [30] Priming with a "simplified regimen" of HIV-1 DNA vaccine is as good as a "standard regimen" when boosted with heterologous HIV-1 MVA vaccine
    Munseri, P.
    Kroidl, A.
    Nilsson, C.
    Moshiro, C.
    Aboud, S.
    Joachim, A.
    Geldmacher, C.
    Aris, E.
    Buma, D.
    Lyamuya, E.
    Gotch, F.
    Godoy-Ramirez, K.
    Pallangyo, K.
    Maboko, L.
    Marovich, M.
    Robb, M.
    Hoelscher, M.
    Janabi, M.
    Mann, P.
    Joseph, S.
    Mfinanga, S.
    Stoehr, W.
    Mhalu, F.
    Wahren, B.
    Biberfeld, G.
    McCormack, S.
    Sandstrom, E.
    Bakari, M.
    RETROVIROLOGY, 2012, 9
12345